Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
La Revue Du Praticien
|
December 6, 2011
[Hypertriglyceridemia: therapeutic strategy]
Christine Cugnet-Anceau, Myriam Moret, Philippe Moulin
Bulletin Du Cancer
|
December 28, 2019
[Thyroid dysfunctions secondary to cancer immunotherapy]
Christine Cugnet Anceau, Juliette Abeillon, Denis Maillet, et al.
Acta Diabetologica
|
December 4, 2018
Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?
Lucien Marchand, Sophie Reffet, Stéphane Dalle, et al.
Annales De Pathologie
|
January 16, 2022
[Rapid diagnosis for liquid-based fine needle aspiration of thyroid nodules]
Alexia Gazeu, Christine Cugnet Anceau, Lucie Ravella, et al.
Journal of Clinical Medicine
|
October 17, 2020
Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up
Manon Levy, Juliette Abeillon, Stéphane Dalle, et al.
Acta Diabetologica
|
August 20, 2019
The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
Lucien Marchand, Emmanuel Disse, Stéphane Dalle, et al.
Medicina (Kaunas, Lithuania)
|
January 25, 2025
Impairment of Microcirculation Parameters in Patients with a History of Diabetic Foot Ulcers
Julien Vouillarmet, Audrey Josset-Lamaugarny, Myriam Moret, et al.
Bulletin Du Cancer
|
March 24, 2020
[Checkpoint inhibitors-induced hypophysitis]
Juliette Abeillon du Payrat, Christine Cugnet-Anceau, Denis Maillet, et al.
Virchows Archiv : an International Journal of Pathology
|
April 3, 2020
Poorly differentiated thyroid carcinoma with pleomorphic giant cells-a case report
Alexia Gazeu, Jonathan Lopez, Serge Guyetant, et al.
Acta Diabetologica
|
October 5, 2018
Diabetes mellitus induced by PD-1 and PD-L1 inhibitors: description of pancreatic endocrine and exocrine phenotype
Lucien Marchand, Arnaud Thivolet, Stéphane Dalle, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
La Revue Du Praticien
|
December 6, 2011
[Hypertriglyceridemia: therapeutic strategy]
Christine Cugnet-Anceau, Myriam Moret, Philippe Moulin
Bulletin Du Cancer
|
December 28, 2019
[Thyroid dysfunctions secondary to cancer immunotherapy]
Christine Cugnet Anceau, Juliette Abeillon, Denis Maillet, et al.
Acta Diabetologica
|
December 4, 2018
Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?
Lucien Marchand, Sophie Reffet, Stéphane Dalle, et al.
Annales De Pathologie
|
January 16, 2022
[Rapid diagnosis for liquid-based fine needle aspiration of thyroid nodules]
Alexia Gazeu, Christine Cugnet Anceau, Lucie Ravella, et al.
Journal of Clinical Medicine
|
October 17, 2020
Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up
Manon Levy, Juliette Abeillon, Stéphane Dalle, et al.
Acta Diabetologica
|
August 20, 2019
The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
Lucien Marchand, Emmanuel Disse, Stéphane Dalle, et al.
Medicina (Kaunas, Lithuania)
|
January 25, 2025
Impairment of Microcirculation Parameters in Patients with a History of Diabetic Foot Ulcers
Julien Vouillarmet, Audrey Josset-Lamaugarny, Myriam Moret, et al.
Bulletin Du Cancer
|
March 24, 2020
[Checkpoint inhibitors-induced hypophysitis]
Juliette Abeillon du Payrat, Christine Cugnet-Anceau, Denis Maillet, et al.
Virchows Archiv : an International Journal of Pathology
|
April 3, 2020
Poorly differentiated thyroid carcinoma with pleomorphic giant cells-a case report
Alexia Gazeu, Jonathan Lopez, Serge Guyetant, et al.
Acta Diabetologica
|
October 5, 2018
Diabetes mellitus induced by PD-1 and PD-L1 inhibitors: description of pancreatic endocrine and exocrine phenotype
Lucien Marchand, Arnaud Thivolet, Stéphane Dalle, et al.
Page
of 2